4 ms·

At least one for Ebola, IIRC.

• dnautics 5y ago
  so, no long-term studies.
  • ceejayoz 5y ago
    The Ebola vaccine in question has been tested in humans since 2015. How long-term are you looking for?
    • dnautics 5y ago
      more than 5 years? Cancer risk, etc. is probably something decadal in scope.
      • lbeltrame 5y ago
        Biology doesn't work like that. Certainly not for replication-deficient adenoviruses used by AZ, Gamaleya and J&J.
        • dnautics 5y ago
          Plenty of replication deficient things cause cancer, for example asbestos or igf-1. I highly doubt you can rule out accidental crosstalk between elicited immune antibodies and every oncogenic human receptor.